	普通株資本		日付
Acadia Pharmaceuticals	USD 169.18M	470K	2025-12
Adma Biologics	USD 237.88M	457K	2025-12
ALKERMES	USD 166.46M	855K	2026-03
Alterity Therapeutics Limited	AUD 10.88B	10.66B	2025-12
AstraZeneca	USD 1.55B	73K	2026-03
BioCryst Pharmaceuticals	USD 213.06M	2.54M	2025-12
Bristol-Myers Squibb	USD 2.04B	1.74B	2025-09
Cipla	INR 807.78M	17K	2026-03
Clal Biotechnology	ILS 1.61M	0	2022-12
Compugen	USD 94.55M	1.02M	2025-12
CSL	USD 482.13M	93.87M	2025-12
Eli Lilly	USD 943.5M	3.33M	2026-03
Esperion Therapeutics	USD 245.22M	39.79M	2025-12
GlaxoSmithKline	GBP 4.05B	20.6M	2026-03
Grifols	EUR 680.58M	846.11K	2025-12
Halozyme Therapeutics	USD 118.52M	741K	2026-03
Ionis Pharmaceuticals	USD 165.9M	3.93M	2026-03
J&J	USD 2.41B	1.74M	2025-12
Merck	USD 2.47B	12.72M	2025-12
Minerva Neurosciences	USD 1000	0	2024-09
Neurocrine Biosciences	USD 100.6M	500K	2026-03
Novartis	USD 1.91B	60K	2026-03
Novavax	USD 162.58M	106K	2025-12
Pfizer	USD 5.7B	13M	2026-03
Roche Holding	CHF 795.62M	699.54K	2025-12
Sanofi	EUR 1.21B	8.25M	2026-03
Takeda	JPY 1.58B	241K	2026-03
Vanda Pharmaceuticals	USD 58K	0	2024-12